Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 4031-4040 Newer>

Chemistry World August 15, 2007 James Mitchell Crow	From Genes to Kilos A biotechnology facility with a difference has opened on Teesside, UK - this one is open access. Its objective is to help turn bright biotech ideas into commercial success.
The Motley Fool August 15, 2007 Billy Fisher	Adversity Continues for Avandia Avandia and Actos receive black box labels from the FDA. The two diabetes medications have been linked to an increase in heart failure.
The Motley Fool August 15, 2007 Brian Lawler	Call for Change at Trimeris A shareholder group criticizes tiny Trimeris about its spending on research. In an SEC filing, HealthCor, which owns 15% of the outstanding shares, called for the pharmaceutical company to cut back on its research and development expenses and to explore selling the company.
The Motley Fool August 15, 2007 Brian Orelli	Buffett's Drug Deals During the most recent quarter Berkshire Hathaway has increased their holdings in several battered pharmaceutical and medical stocks.
The Motley Fool August 15, 2007 Brian Orelli	Little Fish in a Big Pond Small generic-drug maker Caraco Pharmaceutical Laboratories holds its own in a sector where big is almost always better. It does so by having made an intelligent partnership deal and by expanding its product line.
The Motley Fool August 14, 2007 Brian Lawler	Alexza's Announcement Alexza files second-quarter results and announces the expansion of its drug pipeline. The biotech company estimates that its technology could work with nearly 200 already marketed drugs.
The Motley Fool August 14, 2007 Brian Orelli	A No-Win Situation Johnson & Johnson is suing the beloved American Red Cross for trademark infringement. Johnson & Johnson just needs to walk a fine line between having its brand eroded by the Red Cross and having its brand eroded by a public relations nightmare.
The Motley Fool August 14, 2007 Billy Fisher	A Surging Small Cap in Canada Drugmaker Axcan reports a record third-quarter. Investors, this stock has soared more than 42% over the past 52 weeks.
InternetNews August 13, 2007 Larry Barrett	IBM's Tonic For Drug-Tracking Blues The latest version of IBM's WebSphere RFID Information Center software includes a new ePedigree feature that lets pharmaceutical companies create an electronic certificate of authenticity for every bottle, vial and package that wends its way through their supply chains.
The Motley Fool August 13, 2007 Rich Smith	ViaCell Sees the Light Despite rising sales at its trademark ViaCord umbilical cord blood storage service, and gross margin from this service rising in tandem, the firm's operating and net results remain mired in thick red ink. Investors, take note.
<Older 4031-4040 Newer> Return to current articles.